Chemokines in Physiological and Pathological Bone Remodeling.

Current research explores how immune system molecules influence bone remodeling. While osteoclasts and osteoblasts regulate bone turnover, their interactions with immune signaling remain unclear. Prior studies have shown immune cells affect bone metabolism, but specific chemokine roles are not fully understood. This gap motivated investigations into how chemokines might regulate bone cells. No prior work had resolved whether chemokine signaling is essential for bone remodeling. Researchers have identified immune molecules as potential regulators of bone health. However, the exact mechanisms of chemokine involvement remain uncertain. This uncertainty drives the need to clarify how chemokines influence bone cell function.

This review aims to clarify how chemokines influence bone remodeling. The focus is on chemokine signaling in osteoclasts and osteoblasts. The goal is to determine whether chemokines affect bone formation or resorption. The study addresses whether chemokine pathways are involved in physiological and pathological conditions. The motivation is to understand how chemokines might contribute to diseases like osteoporosis. The review also examines whether chemokines interact with other immune molecules in bone. The authors seek to synthesize findings from mouse models and in vitro studies. This synthesis aims to reveal how chemokine signaling impacts skeletal cell behavior.

The review approach includes analyzing published studies on chemokine signaling in bone. The authors focus on C-C and C-X-C chemokines and their receptors. They examine how chemokines influence osteoclast and osteoblast activity. The methods involve compiling data from in vivo and in vitro experiments. The authors assess whether chemokine signaling is necessary for bone remodeling. They evaluate evidence from mouse deficiency models to determine chemokine roles. The approach includes comparing chemokine subgroups and their receptor interactions. The synthesis highlights established subsets of chemokines with known effects on bone.

The strongest finding is that chemokines regulate bone cell function through autocrine and paracrine mechanisms. CX3CL1 is the only chemokine shown to influence bone remodeling. C-C chemokines bind to 10 receptors, while C-X-C chemokines bind to seven. Mouse deficiency models support chemokine signaling in bone remodeling. Specific chemokines affect osteoclast differentiation and activity. Some chemokines also regulate osteoblast function and bone formation. The evidence suggests chemokine signaling is involved in inflammation-induced bone loss. These findings suggest a crosstalk between immune signaling and bone remodeling.

The authors synthesize evidence that chemokines influence bone remodeling. They propose that chemokine signaling is involved in both physiological and pathological conditions. The review highlights that chemokines may regulate osteoclast and osteoblast activity. The findings suggest a role for chemokines in diseases like osteoporosis. The authors state that chemokine signaling is necessary for bone cell interactions. The synthesis supports the idea of a crosstalk between immune and skeletal systems. The authors suggest that chemokine pathways are clinically relevant. These conclusions are based on in vivo and in vitro evidence from published studies.